HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers

Journal: Journal of Clinical Investigation

Published: 2018-07-19

DOI: 10.1172/jci120549

Affiliations: 15

Authors: 25

Go to article
Institutions FC
Brigham and Women's Hospital (BWH), United States of America (USA) 0.32
Ragon Institute of MGH, MIT and Harvard, United States of America (USA) 0.18
Harvard T.H. Chan School of Public Health, United States of America (USA) 0.08
University of Alabama at Birmingham (UAB), United States of America (USA) 0.06
Temple University, United States of America (USA) 0.04
UMass Medical School-Baystate, United States of America (USA) 0.04
UNC School of Medicine, United States of America (USA) 0.04
University of California, Los Angeles (UCLA), United States of America (USA) 0.04
UCSF-Gladstone Center for AIDS Research (CFAR), United States of America (USA) 0.04
College of Medicine - Tucson, Arizona, United States of America (USA) 0.04
Case Western Reserve University (CWRU), United States of America (USA) 0.04
Harvard Division of Medical Sciences (DMS), United States of America (USA) 0.02
Simon Fraser University (SFU), Canada 0.02
BC Centre for Excellence in HIV/AIDS, UBC, Canada 0.02
Massachusetts General Hospital (MGH), United States of America (USA) 0.02

Return